Browse result page of CancerPDF Database

Please click on CancerPDF_ID for detailed information about peptide.

CancerPDF_IDPeptide seqProtein NameFluidMass/ZProfiling TechniqueCancer Type Expression RegulationPUBMED ID
CancerPDF_ID12693 VSFLSALEEYTKKLNTQApolipoprotein A-ISerum1970.984MALDI-TOFBreast cancer "Upregulated with the fold change of 0.57 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 0.88, Upregulated in BC vs healthy with 0.925 fold change" 27058005
CancerPDF_ID12694 HTFMGVVSLGSPSGEVSHPRKTAlpha-2-HS-glycoproteinSerum2326.204MALDI-TOFBreast cancer "Upregulated with the fold change of 0.58 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.25, Upregulated in BC vs healthy with 1.217 fold change" 27058005
CancerPDF_ID12695 HRIHWEComplement C3Serum877.0667MALDI-TOFBreast cancer "Upregulated with the fold change of 1.19 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.25, Upregulated in BC vs healthy with 1.065 fold change" 27058005
CancerPDF_ID12696 IHWESASLLComplement C3Serum1055.082MALDI-TOFBreast cancer "Upregulated with the fold change of 1.21 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.27, Upregulated in BC vs healthy with 1.126 fold change" 27058005
CancerPDF_ID12697 SSKITHRIHComplement C3Serum1078.125MALDI-TOFBreast cancer "Upregulated with the fold change of 1.03 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.19, Upregulated in BC vs healthy with 1.006 fold change" 27058005
CancerPDF_ID12698 SVQLTEKRMDComplement C3Serum1206.7MALDI-TOFBreast cancer "Upregulated with the fold change of 1.02 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.13, Upregulated in BC vs healthy with 1.024 fold change" 27058005
CancerPDF_ID12699 RIHWESASLLComplement C3Serum1211.694MALDI-TOFBreast cancer "Upregulated with the fold change of 1.17 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.22, Upregulated in BC vs healthy with 1.157 fold change" 27058005
CancerPDF_ID12700 HRIHWESASLLComplement C3Serum1348.755MALDI-TOFBreast cancer "Upregulated with the fold change of 1.59 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.13, Upregulated in BC vs healthy with 1.042 fold change" 27058005
CancerPDF_ID12701 THRIHWESASLLComplement C3Serum1449.804MALDI-TOFBreast cancer "Upregulated with the fold change of 1.52 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.25, Upregulated in BC vs healthy with 1.134 fold change" 27058005
CancerPDF_ID12702 SKITHRIHWESASComplement C3Serum1551.893MALDI-TOFBreast cancer "Upregulated with the fold change of 1.18 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.17, Upregulated in BC vs healthy with 1.156 fold change" 27058005
CancerPDF_ID12703 ITHRIHWESASLLComplement C3Serum1562.888MALDI-TOFBreast cancer "Upregulated with the fold change of 1.30 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.22, Upregulated in BC vs healthy with 1.134 fold change" 27058005
CancerPDF_ID12704 SVQLTEKRMDKVGKComplement C3Serum1634.944MALDI-TOFBreast cancer "Upregulated with the fold change of 0.95 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.04, Upregulated in BC vs healthy with 1.049 fold change" 27058005
CancerPDF_ID12705 KITHRIHWESASLLComplement C3Serum1690.987MALDI-TOFBreast cancer "Upregulated with the fold change of 2.19 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.36, Upregulated in BC vs healthy with 1.341 fold change" 27058005
CancerPDF_ID12706 SKITHRIHWESASLLComplement C3Serum1778.018MALDI-TOFBreast cancer "Upregulated with the fold change of 2.10 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.37, Upregulated in BC vs healthy with 1.343 fold change" 27058005
CancerPDF_ID12707 KITHRIHWESASLLRComplement C3Serum1847.095MALDI-TOFBreast cancer "Upregulated with the fold change of 1.26 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.30, Upregulated in BC vs healthy with 1.623 fold change" 27058005
CancerPDF_ID12708 SSKITHRIHWESASLLComplement C3Serum1865.05MALDI-TOFBreast cancer "Upregulated with the fold change of 2.06 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.35, Upregulated in BC vs healthy with 1.344 fold change" 27058005
CancerPDF_ID12709 SSKITHRIHWESASLLRComplement C3Serum2021.146MALDI-TOFBreast cancer "Upregulated with the fold change of 1.02 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.19, Upregulated in BC vs healthy with 1.844 fold change" 27058005
CancerPDF_ID12710 GFKSHALQLNNRQIComplement C4Serum1625.946MALDI-TOFBreast cancer "Upregulated with the fold change of 0.68 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 0.78, Upregulated in BC vs healthy with 0.763 fold change" 27058005
CancerPDF_ID12711 NGFKSHALQLNNRQComplement C4Serum1626.912MALDI-TOFBreast cancer "Upregulated with the fold change of 0.56 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 0.80, Upregulated in BC vs healthy with 0.754 fold change" 27058005
CancerPDF_ID12712 NGFKSHALQLNNRQIComplement C4Serum1739.971MALDI-TOFBreast cancer "Upregulated with the fold change of 0.76 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 0.83, Upregulated in BC vs healthy with 0.796 fold change" 27058005
CancerPDF_ID12713 GFKSHALQLNNRQIRComplement C4Serum1782.012MALDI-TOFBreast cancer "Upregulated with the fold change of 1.73 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.16, Upregulated in BC vs healthy with 1.092 fold change" 27058005
CancerPDF_ID12714 NGFKSHALQLNNRQIRComplement C4Serum1896.068MALDI-TOFBreast cancer "Upregulated with the fold change of 0.45 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.00, Upregulated in BC vs healthy with 0.968 fold change" 27058005
CancerPDF_ID12715 HFFFPKClusterinSerum822.485MALDI-TOFBreast cancer "Upregulated with the fold change of 0.31 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.10, Upregulated in BC vs healthy with 1.029 fold change" 27058005
CancerPDF_ID12716 FPKSRIVClusterinSerum846.533MALDI-TOFBreast cancer "Upregulated with the fold change of 0.50 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.21, Upregulated in BC vs healthy with 1.139 fold change" 27058005
CancerPDF_ID12717 HFFFPKSRIVClusterinSerum1277.758MALDI-TOFBreast cancer "Upregulated with the fold change of 0.39 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.17, Upregulated in BC vs healthy with 1.117 fold change" 27058005
CancerPDF_ID12718 RPHFFFPKSRIVClusterinSerum1530.912MALDI-TOFBreast cancer "Upregulated with the fold change of 0.26 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.16, Upregulated in BC vs healthy with 1.106 fold change" 27058005
CancerPDF_ID12719 AVPPNNSNAAEDDLPTVELQGVVPRCoagulation factor XIII A chainSerum2602.306MALDI-TOFBreast cancer "Upregulated with the fold change of 0.47 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.04, Upregulated in BC vs healthy with 1.073 fold change" 27058005
CancerPDF_ID12720 FLAEGGGVRFibrinogen alpha chainSerum905.065MALDI-TOFBreast cancer "Upregulated with the fold change of 1.28 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.35, Upregulated in BC vs healthy with 1.203 fold change" 27058005
CancerPDF_ID12721 SSSYSKQFTSSTSFibrinogen alpha chainSerum1396.795MALDI-TOFBreast cancer "Upregulated with the fold change of 0.57 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.01, Upregulated in BC vs healthy with 0.963 fold change" 27058005
CancerPDF_ID12722 NRGDSTFESKSYKMFibrinogen alpha chainSerum1665.957MALDI-TOFBreast cancer "Upregulated with the fold change of 0.65 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.06, Upregulated in BC vs healthy with 1.083 fold change" 27058005
CancerPDF_ID12723 SSSYSKQFTSSTSYNRGDSTFESFibrinogen alpha chainSerum2553.201MALDI-TOFBreast cancer "Upregulated with the fold change of 0.60 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 0.85, Upregulated in BC vs healthy with 0.992 fold change" 27058005
CancerPDF_ID12724 DEAGSEADHEGTHSTKRGHAKSRPVFibrinogen alpha chainSerum2659.323MALDI-TOFBreast cancer "Upregulated with the fold change of 0.73 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 0.88, Upregulated in BC vs healthy with 1.033 fold change" 27058005
CancerPDF_ID12725 SSSYSKQFTSSTSYNRGDSTFESKSFibrinogen alpha chainSerum2768.32MALDI-TOFBreast cancer "Upregulated with the fold change of 1.35 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.18, Upregulated in BC vs healthy with 1.074 fold change" 27058005
CancerPDF_ID12726 SSYSKQFTSSTSYNRGDSTFESKSYFibrinogen alpha chainSerum2931.376MALDI-TOFBreast cancer "Upregulated with the fold change of 0.79 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.00, Upregulated in BC vs healthy with 1.128 fold change" 27058005
CancerPDF_ID12727 KMADEAGSEADHEGTHSTKRGHAKSRPVFibrinogen alpha chainSerum3005.608MALDI-TOFBreast cancer "Upregulated with the fold change of 1.73 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 2.39, Upregulated in BC vs healthy with 2.324 fold change" 27058005
CancerPDF_ID12728 SSSYSKQFTSSTSYNRGDSTFESKSYKMFibrinogen alpha chainSerum3206.443MALDI-TOFBreast cancer "Upregulated with the fold change of 1.44 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.05, Upregulated in BC vs healthy with 0.958 fold change" 27058005
CancerPDF_ID12729 SSSYSKQFTSSTSYNRGDSTFESKSYKMAFibrinogen alpha chainSerum3277.592MALDI-TOFBreast cancer "Upregulated with the fold change of 1.43 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.11, Upregulated in BC vs healthy with 0.942 fold change" 27058005
CancerPDF_ID12730 QAGAAGSRMNFRPGVLSInter-alpha-trypsin inhibitor heavy chain H5Serum1717.941MALDI-TOFBreast cancer "Upregulated with the fold change of 0.91 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 0.93, Upregulated in BC vs healthy with 1.276 fold change" 27058005
CancerPDF_ID12731 QAGAAGSRMNFRPGVLSSInter-alpha-trypsin inhibitor heavy chain H5Serum1804.918MALDI-TOFBreast cancer "Upregulated with the fold change of 0.93 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.04, Upregulated in BC vs healthy with 1.080 fold change" 27058005
CancerPDF_ID12732 YLQGAKIPKPEASFSPRInter-alpha-trypsin inhibitor heavy chain H5Serum1889.031MALDI-TOFBreast cancer "Upregulated with the fold change of 1.14 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.08, Upregulated in BC vs healthy with 1.244 fold change" 27058005
CancerPDF_ID12733 YYLQGAKIPKPEASFSPRInter-alpha-trypsin inhibitor heavy chain H5Serum2051.125MALDI-TOFBreast cancer "Upregulated with the fold change of 0.80 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.02, Upregulated in BC vs healthy with 1.047 fold change" 27058005
CancerPDF_ID12734 SRQLGLPGPPDVPDHAAYHPFInter-alpha-trypsin inhibitor heavy chain H5Serum2271.203MALDI-TOFBreast cancer "Upregulated with the fold change of 0.99 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 0.93, Upregulated in BC vs healthy with 1.221 fold change" 27058005
CancerPDF_ID12735 NVHSGSTFFKYYLQGAKIPKPEAInter-alpha-trypsin inhibitor heavy chain H5Serum2582.393MALDI-TOFBreast cancer "Upregulated with the fold change of 0.38 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 0.62, Upregulated in BC vs healthy with 0.975 fold change" 27058005
CancerPDF_ID12736 GVLSSRQLGLPGPPDVPDHAAYHPFInter-alpha-trypsin inhibitor heavy chain H5Serum2627.365MALDI-TOFBreast cancer "Upregulated with the fold change of 0.51 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 0.86, Upregulated in BC vs healthy with 0.931 fold change" 27058005
CancerPDF_ID12737 PGVLSSRQLGLPGPPDVPDHAAYHPFInter-alpha-trypsin inhibitor heavy chain H5Serum2724.46MALDI-TOFBreast cancer "Upregulated with the fold change of 0.22 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 0.72, Upregulated in BC vs healthy with 1.080 fold change" 27058005
CancerPDF_ID12738 NVHSGSTFFKYYLQGAKIPKPEASFSPRInter-alpha-trypsin inhibitor heavy chain H5Serum3156.679MALDI-TOFBreast cancer "Upregulated with the fold change of 0.52 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.11, Upregulated in BC vs healthy with 1.158 fold change" 27058005
CancerPDF_ID12739 MNFRPGVLSSRQLGLPGPPDVPDHAAYHPFInter-alpha-trypsin inhibitor heavy chain H5Serum3272.752MALDI-TOFBreast cancer "Upregulated with the fold change of 0.42 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 0.89, Upregulated in BC vs healthy with 1.036 fold change" 27058005
CancerPDF_ID12740 MNFRPGVLSSRQLGLPGPPDVPDHAAYHPFInter-alpha-trypsin inhibitor heavy chain H5Serum3288.759MALDI-TOFBreast cancer "Upregulated with the fold change of 0.34 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 0.85, Upregulated in BC vs healthy with 1.126 fold change" 27058005
CancerPDF_ID12741 QAGAAGSRMNFRPGVLSSRQLGLPGPPDVPDHAAYHPFInter-alpha-trypsin inhibitor heavy chain H5Serum3969.989MALDI-TOFBreast cancer "Upregulated with the fold change of 0.57 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 0.82, Upregulated in BC vs healthy with 1.170 fold change" 27058005
CancerPDF_ID12742 RPPGFSPFKininogen-1Serum904.5017MALDI-TOFBreast cancer "Upregulated with the fold change of 0.29 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.40, Upregulated in BC vs healthy with 0.902 fold change" 27058005
CancerPDF_ID12743 RPPGFSPFRKininogen-1Serum1060.627MALDI-TOFBreast cancer "Upregulated with the fold change of 0.79 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 0.82, Upregulated in BC vs healthy with 0.818 fold change" 27058005
CancerPDF_ID12744 GHKHERDQGHGHQKininogen-1Serum1522.838MALDI-TOFBreast cancer "Upregulated with the fold change of 0.81 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 0.88, Upregulated in BC vs healthy with 1.118 fold change" 27058005
CancerPDF_ID12745 HGHKHERDQGHGHQKininogen-1Serum1659.808MALDI-TOFBreast cancer "Upregulated with the fold change of 0.47 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 0.65, Upregulated in BC vs healthy with 1.231 fold change" 27058005
CancerPDF_ID12746 GHGHKHERDQGHGHQKininogen-1Serum1716.955MALDI-TOFBreast cancer "Upregulated with the fold change of 1.25 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.11, Upregulated in BC vs healthy with 1.154 fold change" 27058005
CancerPDF_ID12747 NLGHGHKHERDQGHGHQKininogen-1Serum1943.95MALDI-TOFBreast cancer "Upregulated with the fold change of 0.45 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 0.43, Upregulated in BC vs healthy with 1.386 fold change" 27058005
CancerPDF_ID12748 HGLGHGHEQQHGLGHGHKFKininogen-1Serum2070.011MALDI-TOFBreast cancer "Upregulated with the fold change of 0.25 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 0.62, Upregulated in BC vs healthy with 1.201 fold change" 27058005
CancerPDF_ID12749 HNLGHGHKHERDQGHGHQKininogen-1Serum2081.006MALDI-TOFBreast cancer "Upregulated with the fold change of 0.43 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 0.71, Upregulated in BC vs healthy with 1.565 fold change" 27058005
CancerPDF_ID12750 GHGLGHGHEQQHGLGHGHKFKininogen-1Serum2127.055MALDI-TOFBreast cancer "Upregulated with the fold change of 0.10 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 0.48, Upregulated in BC vs healthy with 1.279 fold change" 27058005
CancerPDF_ID12751 KHNLGHGHKHERDQGHGHQKininogen-1Serum2209.11MALDI-TOFBreast cancer "Upregulated with the fold change of 0.31 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.29, Upregulated in BC vs healthy with 1.499 fold change" 27058005
CancerPDF_ID12752 KHNLGHGHKHERDQGHGHQRKininogen-1Serum2365.208MALDI-TOFBreast cancer "Upregulated with the fold change of 1.62 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.87, Upregulated in BC vs healthy with 1.340 fold change" 27058005
CancerPDF_ID12753 GGPGGAGVARGGAGGGPNeurograninSerum1251.732MALDI-TOFBreast cancer "Upregulated with the fold change of 1.16 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.07, Upregulated in BC vs healthy with 1.103 fold change" 27058005
CancerPDF_ID12754 TPHPRPAPQSKPLASSGVPERIMS-binding protein-2Serum2053.134MALDI-TOFBreast cancer "Upregulated with the fold change of 0.77 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 0.99, Upregulated in BC vs healthy with 1.495 fold change" 27058005